Dietary inflammatory index and the aging kidney in older women: a 10‑year prospective cohort study by Bondonno, Nicola P. et al.
Edith Cowan University 
Research Online 
ECU Publications Post 2013 
1-1-2020 
Dietary inflammatory index and the aging kidney in older women: 
a 10‑year prospective cohort study 
Nicola P. Bondonno 
Edith Cowan University 
Lauren Blekkenhorst 
Edith Cowan University 
Anna L. Bird 
Joshua R. Lewis 
Edith Cowan University 
Johnathan M. Hodgson 
Edith Cowan University 
See next page for additional authors 
Follow this and additional works at: https://ro.ecu.edu.au/ecuworkspost2013 
 Part of the Medicine and Health Sciences Commons 
10.1007/s00394-019-02160-9 
This is a post-peer-review, pre-copyedit version of an article published in the European Journal of Nutrition. The 
final authenticated version is available online at: https://doi.org/10.1007/s00394-019-02160-9 
Bondonno, N. P., Blekkenhorst, L. C., Bird, A. L., Lewis, J. R., Hodgson, J. M., Shivappa, N., ... & Lim, W. H. (2020). 
Dietary inflammatory index and the aging kidney in older women: a 10-year prospective cohort study. European 
Journal of Nutrition, 59, 3201–3211. 
This Journal Article is posted at Research Online. 
https://ro.ecu.edu.au/ecuworkspost2013/8351 
Authors 
Nicola P. Bondonno, Lauren Blekkenhorst, Anna L. Bird, Joshua R. Lewis, Johnathan M. Hodgson, Nitin 
Shivappa, James R. Hebert, Richard J. Woodman, Germaine Wong, Deborah A. Kerr, Wai H. Lim, and 
Richard L. Prince 
This journal article is available at Research Online: https://ro.ecu.edu.au/ecuworkspost2013/8351 
1 
 
Dietary inflammatory index and the ageing kidney in older women: a 10-year prospective cohort study 
Nicola P. Bondonno1,2, Lauren C. Blekkenhorst1,2, Anna L. Bird3, Joshua R. Lewis1,2,4, Jonathan M. Hodgson1,2, 
Nitin Shivappa5,6,7, James R. Hébert5,6,7, Richard J. Woodman8, Germaine Wong4, Deborah A. Kerr3, Wai H. 
Lim2,9, and Richard L. Prince2,10 
1 School of Medical and Health Sciences, Edith Cowan University, Perth 6009, Western Australia, Australia 
2 Medical School, University of Western Australia, Perth 6009, Western Australia, Australia 
3 Curtin University, School of Public Health, Bentley 6102, Western Australia, Australia 
4 Centre for Kidney Research, Children’s Hospital at Westmead, School of Public Health, Sydney Medical 
School, University of Sydney, Sydney 2145, New South Wales, Australia 
5 Cancer Prevention and Control Program, Arnold School of Public Health, University of South Carolina, 
Columbia, SC 29208 USA 
6 Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, 
Columbia, SC 29208 USA 
7 Connecting Health Innovations LLC, Columbia, SC 29201 USA 
8 Centre for Epidemiology and Biostatistics, College of Medicine and Public Health, Flinders University, 
Adelaide 5042, South Australia, Australia 
9 Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth 6009, Western Australia, Australia 
10 Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Perth 6009, Western Australia, 
Australia 
 
Corresponding author: Nicola Bondonno 
Level 3 Medical Research Foundation Building 




P: +618 9224 0342 
 





The authors wish to thank the staff at the Data Linkage Branch, Hospital Morbidity Data Collection and 2 
Registry of Births, Deaths and Marriages for their work on providing data for this study. 3 
The study was supported by Kidney Health Australia grant S07 10, Healthway Health Promotion Foundation of 4 
Western Australia, Sir Charles Gairdner Hospital Research Advisory Committee Grant and by project grants 5 
254627, 303169 and 572604 from the National Health and Medical Research Council of Australia. The salary of 6 
JRL is supported by a National Health and Medical Research Council of Australia Career Development 7 
Fellowship (ID: 1107474). NPB is funded by a National Health and Medical Research Council Early Career 8 
Fellowship (Grant number APP1159914), Australia. The salary of JMH is supported by a National Health and 9 
Medical Research Council of Australia Senior Research Fellowship, Australia (Grant number APP1116937). 10 
WL is supported by the Raine/University of Western Australia clinical fellowship. NS and JRH were supported 11 
by the United States National Institute for Diabetes, Digestive and Kidney Diseases (grant no. R44DK103377).  12 
None of the funding agencies had any role in the conduct of the study; collection, management, analysis, or 13 
















Purpose: Chronic inflammation plays a role in the pathogenesis of age-related renal disease and the diet can 16 
moderate systemic inflammation. The primary objective of this study was to examine the associations between a 17 
dietary inflammatory index (DII®) score and renal function, the trajectory of renal function decline, and renal 18 
disease-related hospitalizations and/or mortality over 10 years.  19 
Methods: The study was conducted in 1422 Western Australian women without prevalent chronic kidney 20 
disease and aged ≥ 70 years. Baseline dietary data, obtained from a validated food frequency questionnaire, 21 
were used to calculate a DII score for each individual.  22 
Results: In this cohort the mean [range] DII score was 0.19 [-6.14 – 6.39]. A higher DII score was associated 23 
with poorer renal function and a greater renal function decline over 10 years; after multivariable adjustments a 24 
one-unit higher DII score was associated with a 0.55 mL/min/1.73m2 lower eGFR at baseline (p=0.01), and a 25 
0.06 mL/min/1.73m2 greater annual decline in eGFR over 10 years (p=0.05). Restricted cubic splines provide 26 
evidence of a non-linear association between baseline DII score and risk of a renal disease-related event. 27 
Compared to participants in the lowest quintile, those in the highest quintile of DII score were at a higher risk of 28 
experiencing a renal disease-related event (adjusted HR: 2.06, 95% CI: 0.97, 4.37).  29 
Conclusion: Recommending an increased consumption of foods with a higher anti-inflammatory potential could 30 




Chronic kidney disease (CKD) has emerged as a major public health concern and significant driver of healthcare 33 
expenditures [1,2]. The incidence of CKD is steadily increasing, with a global prevalence of up to 13% [3]. 34 
Although a substantial proportion of older individuals in the general population have stage 2-3 CKD, individuals 35 
exhibiting a rapid decline in kidney function have the greatest risk of adverse health outcomes [4].  It has been 36 
suggested that chronic inflammation may play a critical role in the pathogenesis of age-related CKD and/or 37 
kidney function decline [1,5,6], suggesting that attenuation of an inflammatory response could potentially slow 38 
renal decline and/or reduce the risk of CKD-related adverse outcomes. 39 
Over the last decade, the role that diet plays in the regulation of systemic inflammation has become increasingly 40 
apparent [7,8]. Epidemiological studies have shown that the intake of anti-inflammatory foods and nutrients, 41 
primarily fruit, vegetables, fibre, omega-3 polyunsaturated fatty acids and vitamins, are associated with lower 42 
serum levels of inflammatory biomarkers in persons at risk of developing CKD [9,6,10]. In contrast, pro-43 
inflammatory diets typically high in refined grains, full fat dairy, red meat, total fat, and saturated fat are 44 
positively associated with higher levels of inflammatory biomarkers [11] and a higher incidence of CKD [12].  45 
The literature-derived Dietary Inflammatory Index (DII®), based on 45 food parameters, is a suggested indicator 46 
of the inflammatory potential of whole dietary patterns[13].  Previous research has proposed independent 47 
associations between pro-inflammatory dietary patterns, indicated by high DII scores, and asthma[14], 48 
cardiovascular disease[15], diabetes[16] and several cancers[17-20].  There is evidence that pro-inflammatory 49 
diets are associated with systemic inflammation and reduced renal function[21]. However, associations between 50 
DII, temporal change in renal function and renal disease-related adverse health outcomes, a large and growing 51 
public health concern, remain unknown.   52 
The aims of this study were to examine the associations between DII scores and renal function decline, and to 53 
estimate the risk of renal disease-related hospitalization and/or mortality in a cohort of elderly women in 54 
Australia. We hypothesized that, in a population of elderly women, a pro-inflammatory diet, characterized by a 55 
higher DII score, would be associated with poorer baseline renal function and a more rapid renal function 56 





Study Population  60 
Participants were originally recruited in 1998 for a 5-year double-blind, randomised, controlled trial of oral 61 
calcium supplements; the Calcium Intake Fracture Outcome Study (CAIFOS)[22]. Briefly, 1500 women aged 62 
70 years and above were recruited from the Western Australian general population by mail using the Electoral 63 
Roll. All participants in the study were ambulatory and had an expected survival beyond 5 years. Participants 64 
received either 1.2 g of elemental calcium as calcium carbonate or a matching placebo daily. Following the 65 
completion of the study, participants were followed for a further ten years as part of the Perth Longitudinal 66 
Study of Aging in Women (PLSAW). Participants were similar to the age-matched general population in terms 67 
of disease burden and pharmaceutical consumption[22]. The current study reports on 1,422 of the total 1,500 68 
participants included in the PLSAW.  As shown in Figure 1, participants who did not complete a food 69 
frequency questionnaire (FFQ) at baseline and those with implausible energy intakes [<2,092 kJ/day 70 
(<500kcal/day) and >14,644 kJ/day (>3,500kcal/day)] were excluded from the analysis (n=32), which is 71 
consistent with other studies of this cohort[23,1]. Furthermore, all women with missing data (n=21) or a history 72 
of prevalent renal disease at baseline were excluded (n=25).   73 
All participants provided written informed consent for the study and for the follow up of electronic health 74 
records. Ethics approval for the study was granted by The Human Ethics Committee of the University of 75 
Western Australia (approval number 05/06/004/H50) and the Human Research Ethics Committee of the Western 76 
Australian Department of Health (DOH HREC) approved the data linkage study (approval number #2009/24).  77 
Dietary Assessment and Dietary Inflammatory Index Score 78 
Diet was assessed at baseline (1998) using a semi-quantitative FFQ developed by the Cancer Council of 79 
Victoria[24]. This FFQ has been validated against two 7-day weighed food records and was found to have 80 
reasonable correlations for all nutrients, except retinol, due to the inclusion of liver in the weighed food records, 81 
but not the FFQ[25]. Nutrient and energy intakes were estimated based on usual portion size and the frequency 82 
of consumption[26]. The DII was intended for use in large epidemiological studies, with the intention of 83 
examining whether DII scores are associated with risk of chronic diseases. A description of the development of 84 
the DII is available elsewhere[13]. Briefly, the DII is based on 1,943 scientific articles published between 1950 85 
and 2010 scoring 45 dietary components according to whether they increased (+1), decreased (-1) or had no 86 
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effect (0) on six inflammatory markers [interleukin (IL)-1 beta, IL-4, IL-6, IL-10, tumor necrosis factor-alpha, 87 
and C-reactive protein). Articles were weighted by study characteristics; using these weighted values, a specific 88 
inflammatory effect score was derived for each of the 45 food parameters. In the current study, the DII score 89 
was calculated using the corresponding 32 food parameters available from the FFQ used in this cohort. To 90 
calculate the DII score for each individual, the mean intake of each food parameter was standardized, converted 91 
to centered proportions and then multiplied by the respective food parameter specific inflammatory effect score. 92 
These parameter-specific DII scores were summed to create the overall DII score for each participant in the 93 
study[13]. The 32 food parameters included in the DII score are shown in Supplemental Table 1.  Higher DII 94 
scores represent more pro-inflammatory dietary patterns, whereas lower DII scores represent more anti-95 
inflammatory dietary patterns.  96 
Exposure 97 
DII was both considered as a continuous variable and was categorized into quintiles: Q1 (-6.14, -1.72); Q2 (-98 
1.73, - 0.38); Q3 (-0.39, 0.76); Q4 (0.77, 2.13); Q5 (2.14, 6.39).  99 
Study outcomes 100 
The primary outcomes in this study were the association between DII score and renal function at baseline, 10-101 
year change in renal function, and renal disease-related hospitalizations and deaths (events) over the 10 years of 102 
follow-up. 103 
Renal function (eGFR) 104 
Fasting blood samples for creatinine and cystatin C were collected at baseline (1998), 5 years (2003), and 10 105 
years (2008), as described elsewhere[27,4]. Estimated glomerular filtration rate (eGFR) at each of these time 106 
points was calculated from creatinine and cystatin C (CKD-EPI-creatinine and cystatin C) using the Chronic 107 
Kidney Disease Epidemiology Collaboration (CKD-EPI) equation[28]. The annual rate of change in eGFR over 108 
10 years of follow-up was estimated by calculating the slope of the line between eGFR measurements at two or, 109 




Plasma total L-homocysteine (tHcy) was measured using a Fluorescence Polarization Immuno-assay as 112 
described previously [29]. High sensitivity C reactive protein (hs-CRP) was measured using a highly sensitive 113 
latex immunoassay with a measurement range of 0.02 to 48.00 mg/dL (CRP Vario, Sentinel Diagnostics, Abbott 114 
Diagnostics Europe, Milan, Italy). 115 
10-year Renal Disease Hospitalisations and Mortality  116 
Prevalent renal disease-related events were captured using a follow-up period of 18 years between 1980 and 117 
1998 while incident events between 1998 and 2008 were retrieved from the Western Australian Data Linkage 118 
System (WADLS) using the diagnoses codes from the International Classification of Diseases, Injuries and 119 
Causes of Death Clinical Modification (ICD-9-CM)[30] and the International Statistical Classification of 120 
Diseases and Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM)[31]. WADLS is a 121 
comprehensive, population-based linkage system connecting 40 years of data from over 30 health-related 122 
datasets for Western Australian residents using ICD codes[32].  A renal disease event was defined as first-time 123 
renal disease-related hospitalization or renal disease-related death. Codes used for identification of renal disease 124 
hospitalizations included ICD-9-CM codes 580–583, ICD-10-AM codes N00–08, ICD-9-CM codes 593.3–125 
593.5, 593.7 and 590–591, ICD-10-AM codes N09–16, ICD-9-CM codes 584–586, ICD-10-AM codes N17–19, 126 
ICD-9-CM code 403, and ICD-10-AM codes I12 in either the participant’s primary discharge diagnosis or 127 
additional diagnoses fields. Renal disease-related death ICD codes included all available diagnostic information 128 
that comprised Parts 1 and 2 of the death certificate. All diagnosis text fields from the death certificate were 129 
used to ascertain the cause(s) of deaths where these data were not yet available from the WADLS.  130 
Covariates 131 
Baseline questionnaires were used to determine values for potential confounding variables including age, use of 132 
antihypertensive medication, use of statins, use of NSAIDs for musculoskeletal pain, and current/previous 133 
smoking. Smoking status was defined as non-smoker or ex-smoker/current smoker if a participant had ever 134 
consumed more than 1 cigarette per day for more than 3 months during their lifetime. Weight (kg) was 135 
measured using digital scales, height (m) was assessed using a stadiometer and body mass index (BMI) was 136 
calculated in kg/m2. Physical activity was assessed by asking participants about their participation in regular 137 
physical activities undertaken in the three months prior to their baseline visit [33]. Activity levels (kJ/d) were 138 
calculated using a validated method, taking into consideration the type of activity, time engaged in the activity, 139 
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and body weight[34]. Total energy intakes were estimated from the FFQ. Prevalent cancer and atherosclerotic 140 
vascular disease (ASVD) at baseline was determined from primary discharge diagnoses from hospital records 141 
(1980–1998). ICD codes for prevalent cancer included (ICD-9-CM codes C00-C99). ICD codes for prevalent 142 
ASVD included: ischemic heart disease (ICD-9-CM codes 410–414); heart failure (ICD-9-CM code 428); 143 
cerebrovascular disease excluding hemorrhage (ICD-9-CM codes 433–438); and peripheral arterial disease 144 
(ICD-9-CM codes 440–444). Participants provided their previous medical history and current medications, with 145 
this information verified by their General Practitioner where possible. These data were coded using the 146 
International Classification of Primary Care – Plus (ICPC-Plus) method[35], allowing for aggregation of 147 
different terms for similar pathologic entities as defined by the ICD-10 coding system, and then used to 148 
determine the presence of diabetes at baseline. 149 
Statistical Analysis 150 
Analyses were undertaken using STATA/IC® 14.2 (StataCorp LLC), SAS® 9.4 (SAS Institute Inc) and R® 151 
statistics (R Core Team[36]). Statistical significance was set at p≤0.05 (two-tailed) for all tests. For all analyses, 152 
two models of adjustment were fit: 1) minimally-adjusted: age and energy intake; and 2) multivariable-adjusted: 153 
age, energy intake, treatment code (calcium or placebo), BMI, smoking status, physical activity, alcohol intake, 154 
diabetes status, use of antihypertensive medication, prevalent ASVD, statin use, and use of NSAIDs for joint 155 
pain. Generalized additive models were used to examine the association between DII and both baseline eGFR 156 
and the trajectory of eGFR change over the 10 years of follow-up. In the latter analysis, the time-points at which 157 
eGFR was measured was adjusted for. The associations of DII with biomarkers of inflammation, eGFR, and the 158 
trajectory of eGFR change were assessed by linear regression. Potential nonlinear relationships between DII and 159 
renal disease-related mortality and hospitalisation events were examined using restricted cubic splines, with 160 
hazard ratios (HRs) based on Cox proportional hazards models. HRs with 95% confidence intervals (CIs) were 161 
plotted for each unit of the exposure against the median DII score in quintile 1. Age- and multivariable-adjusted 162 
Cox proportional hazard ratios (HR) and 95% confidence intervals (CIs) for renal events were computed across 163 
quintiles of DII score, where the lowest (least inflammatory) quintile was the referent. Schoenfeld residuals were 164 
used to check the Cox proportional hazards assumptions, with no evidence of violation of this assumption. As 165 
the research question addressed in this paper was aetiological in nature, we did not apply a sub-distribution 166 
proportional hazards model to take into account competing risks[37]. Individuals who died or were lost to 167 
follow-up were censored. As a sensitivity analysis, all participants with a history of cancer at baseline were 168 
excluded and 1,336 were re-analysed. Statistical power was too limited to perform analysis for renal disease-169 
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related hospitalisation and deaths separately (114 renal disease-related hospitalisations and 19 renal disease-170 
related deaths). 171 
Results 172 
Baseline characteristics 173 
In this population of 1,422 postmenopausal women, DII scores were normally distributed with a mean of 0.19 174 
units and a SD of 2.14 units. The baseline characteristics of the study population, overall and stratified by DII 175 
score quintiles [Q1 (-6.14, -1.72); Q2 (-1.73, - 0.38); Q3 (-0.39, 0.76); Q4 (0.77, 2.13); Q5 (2.14, 6.39)], are 176 
shown in Table 1. At baseline, subjects in the highest versus the lowest quintile of DII score had a lower energy 177 
intake, lower level of physical activity and lower eGFR. No other baseline characteristics appeared to differ 178 
across the DII quintiles. Baseline intakes of dietary components that were used to calculate the DII score, for the 179 
total cohort population and stratified by the occurrence of a renal disease-related event, are presented in 180 
Supplemental Table 1. Intakes of trans-fatty acids were higher in participants who suffered from a renal event 181 
(p=0.01). Intakes of the vitamins riboflavin, niacin, folate and vitamin E, the minerals iron, magnesium and 182 
zinc, and isoflavones (from sources other than tea) were lower in participants who had experienced a renal event 183 
(p<0.05 for all). Differences in baseline dietary intakes across DII quintiles are presented in Supplemental 184 
Table 2. After energy adjustment, with the exception of alcohol, retinol equivalents, and garlic, intakes of all 185 
other food parameters used to calculate the DII score were significantly different across DII quintiles (p<0.05). 186 
Aside from carbohydrates and iron, the intakes of food parameters that positively contribute to the DII score 187 
increased as DII quintiles increased while all food parameters that negatively contributed to the DII score 188 
decreased across DII quintiles.  189 
Associations between DII and renal function estimates 190 
Of 1,111 participants with eGFR measured at baseline, the mean ± SD for eGFR was 65.9 ± 12.9 191 
mL/min/1.73m2. Evidence for a linear association between DII score and baseline eGFR can be seen in Figure 2 192 
(p=0.01). After multivariable adjustments a one-unit higher DII score was associated with a 0.55 193 
mL/min/1.73m2 lower eGFR at baseline (p=0.01; Table 2). Of the 1,342 participants still alive after 5 years of 194 
follow-up, eGFR was measured in 1,022; the mean ± SD for eGFR was 61.33 ± 14.19 mL/min/1.73m2. Of the 195 
1,253 participants still alive after 10 years of follow-up, eGFR was measured in 738; the mean ± SD for eGFR 196 
was 60.4 ± 15.8 mL/min/1.73m2. The association between DII score and eGFR at both 5 and 10 years was linear 197 
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(p<0.01). After multivariable adjustments a one-unit higher DII score was associated with a 0.89 198 
mL/min/1.73m2 lower eGFR at 5 years (p<0.01) and a 0.92 mL/min/1.73m2 lower eGFR at 10 years (p=0.01; 199 
Table 2). eGFR was calculated at two or more time points in 998 women, allowing for an estimation of renal 200 
function trajectory (annual rate of change in eGFR) in this subgroup. Figure 3 provides weak evidence that 201 
there is a linear association between DII and renal function trajectory (p=0.08). After multivariable adjustments 202 
a one-unit higher DII score was associated with a 0.06 mL/min/1.73m2 greater annual decline in eGFR (p=0.05; 203 
Table 2).  204 
Associations between DII and biomarkers of inflammation 205 
After multivariable adjustments, a one-unit higher DII score was associated with a 0.46 µmol/L higher baseline 206 
plasma tHcy (p<0.001; Supplementary Table 3). DII score was not significantly associated with baseline levels 207 
of hs-CRP (p=0.57; Supplementary Table 3). 208 
Associations with 10-year renal disease-related events 209 
During 13,013 person-years of follow-up (median follow-up time = 10 years), 123 (8.6%) participants 210 
experienced a renal disease-related event (hospitalization or death). Restricted cubic splines provide evidence of 211 
a non-linear association between baseline DII score and risk of a renal disease-related event (p for non-linearity 212 
= 0.04; Figure 4). Compared to participants with a DII score of -2.6, those with a score >4 had a significantly 213 
higher risk of experiencing a renal disease-related event (HR: 2.35, 95% CI: 1.16, 4.75). Minimal- and 214 
multivariable-adjusted associations between DII score and renal events are shown in Table 3. After 215 
multivariable adjustments, there was evidence that participants in the highest (most pro-inflammatory) quintile 216 
of DII score were at a higher risk of experiencing a renal disease-related event (HR: 2.06, 95% CI: 0.97, 4.37) 217 
compared to those in the lowest quintile. 218 
Sensitivity analysis 219 
Excluding participants with a history of cancer at baseline (n=86) did not change the main findings of the study. 220 
After multivariable adjustments, a one-unit higher DII score was associated with a 0.57 mL/min/1.73m2 (95% 221 
CI: 0.13, 1.01, p=0.01) lower eGFR at baseline and a 0.06 mL/min/1.73m2 (95% CI: 0.00, 0.12, p=0.05) greater 222 
annual decline in eGFR. Furthermore, participants in the highest quintile of DII score had a two times higher 223 
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risk of experiencing a renal disease-related event (HR: 2.00, 95% CI: 0.973 4.28) compared to those in the 224 
lowest quintile. 225 
Discussion  226 
The relationships between the inflammatory potential of the diet, assessed using the DII, renal function and 227 
renal disease-related events were investigated in a cohort of 1,422 postmenopausal women. Evidence suggests 228 
that participants with a higher pro-inflammatory diet score had poorer renal function and a greater decline in 229 
renal function over 10 years of follow-up. Additionally, participants with high DII® score appeared to be at the 230 
highest risk of a renal disease-related event. 231 
Diet is an important and potentially easily modifiable risk factor for chronic disease[38]. A Western-style diet, 232 
characterized by a high intake of added sugar, red meat, refined grains, and high-fat dairy products, contributes 233 
to systemic inflammation (with elevated inflammatory biomarkers)[11] and development of CKD[12]. 234 
Conversely, a Mediterranean-style diet, characterized by a high intake of fruits, vegetables and wholegrains with 235 
a low intake of red meats and saturated fat, attenuates systemic inflammation[39] and may be protective against 236 
the development of CKD[40]. Although the DII score is used to reflect the overall inflammatory potential of the 237 
participants’ diets, the relationship between specific food components included in the calculation of the DII and 238 
renal disease events is more difficult to establish. However, women who experienced renal disease-related 239 
events had higher intakes of pro-inflammatory trans-fatty acids, a dietary component characteristic of a 240 
Western-style diet. Additionally, the intakes of anti-inflammatory dietary components including vitamins 241 
(riboflavin, niacin, folate and vitamin E), minerals (iron, magnesium and zinc), and isoflavones were lower in 242 
women who had experienced renal disease-related events.  243 
Reduced kidney function has been shown to be an independent risk factor for cardiovascular disease and all-244 
cause mortality in the general population, with the risk of end-stage kidney disease increasing exponentially 245 
with eGFR below 60 mL/min/1.73m2[4,41,42]. Although the association between CKD and mortality is well 246 
recognized, the extent of a direct causal pathway remains unclear, since considerable indirect effects exist via an 247 
excess of traditional CVD risk factors. Reduced kidney function is associated with significantly higher serum 248 
levels of inflammatory biomarkers [43,44]. In addition, the DII score is positively associated with circulating 249 
levels of the inflammatory biomarkers, CRP [45,46] and IL-6 [45,47,46,21], suggesting the likelihood of an 250 
inverse association between DII and kidney function. In the present study, participants with a higher DII score 251 
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had a lower eGFR at baseline, suggesting that a pro-inflammatory diet is associated with poorer kidney function. 252 
In line with our findings, recent cross-sectional studies have reported that a higher DII score was associated with 253 
worse kidney function, a higher prevalence of CKD [48], and, in participants with CKD, a higher risk of being 254 
in a later stage of CKD [49].  In a cross-sectional study of 1,942 elderly Swedish men and women, from two 255 
independent cohorts, researchers considered the association between an adapted DII (ADII) and kidney 256 
function[6]. The ADII differs from the DII used in this paper in that it is calculated by modifying an older 257 
version of the DII which uses fewer dietary parameters, is based on reviewing less articles (n=927) and is now 258 
obsolete for reasons described elsewhere [50]. Despite the methodologic deficiencies, the authors demonstrated 259 
that a 1 SD higher ADII score was associated with a 1.8% lower eGFR at baseline (β: −1.8%; 95% CI: −2.7%, 260 
−0.9%; p< 0.001). Mediation analyses revealed that 15% of the association could be explained by increased 261 
plasma levels of CRP. Whether dietary changes to incorporate more anti-inflammatory foods can improve renal 262 
function warrants further investigation.  263 
Temporal change in eGFR may be a more accurate prediction of adverse long-term health outcomes in the 264 
general population compared to a single-time-point eGFR. In a study of 4,380 subjects with 7-year follow-up, 265 
individuals who had experienced a more rapid loss of kidney function, greater than 3 ml/min/1.73m2, were at 266 
more than a 50% higher risk of death and developing CVD, independent of baseline eGFR and traditional CVD 267 
risk factors [51]. In a comparable population, consisting primarily of older white women, a Western-style 268 
dietary pattern correlated directly with a rapid decline of eGFR [52]. To our knowledge, no previous studies 269 
have examined the relationship between DII and renal function decline. Our results show that participants with 270 
the most pro-inflammatory diet had the lowest eGFR at each time-point and experienced the greatest decline in 271 
renal function over 10 years. 272 
To date, no previous prospective cohort study has examined the relationship between DII and renal disease-273 
related events. Our results suggest that the risk of a renal disease-related event is highest in participants with the 274 
most pro-inflammatory diet. However, our findings of a non-linear association suggest that only individuals 275 
with a highly pro-inflammatory diet are at a higher risk. If this proposed association is confirmed to be causal, 276 
individuals at the upper end of the DII score scale should be the primary target for dietary intervention, as they 277 
are likely to experience the most benefit. With projected expenditures of renal disease-related disease reaching 278 
12 billion AUD by 2020 [2], such findings are of great clinical and economic significance.  279 
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There are a number of strengths of this study, including the use of a large prospective cohort of subjects with no 280 
loss to follow-up, combined with use of the literature-derived DII, validated against a variety of inflammatory 281 
markers [45,47,46,21], and the use of an eGFR equation based on creatinine and cystatin C which is a better 282 
measure of true GFR than eGFR equations using creatinine alone [53]. Renal disease-related events were 283 
ascertained through independently reported hospital records, removing the risk of recall bias. Furthermore, 284 
adjusting for a large number of potential confounding factors did not significantly alter the observed relationship 285 
between DII and eGFR. The strengths of this study must be balanced against the limitations; firstly this is an 286 
observational study and as such causality cannot be established. Secondly, the findings are in a cohort of women 287 
of European descent aged ≥ 70 years with adequate nutrition, therefore limiting the ability to generalize findings 288 
to males, other ethnic groups, younger individuals, and those with poor nutrition intakes. Participant DII scores 289 
could only be calculated from 32 of the original 45 dietary components that were available from the FFQ used in 290 
the PLSAW study. Participants only completed an FFQ at baseline meaning that changes in DII scores over time 291 
were not able to be assessed. Additionally, the modest number of event cases resulted in the inability to assess 292 
the risk of renal disease hospitalization and mortality separately.  293 
Conclusion 294 
In the present cohort of women ≥70 years of age, we have shown that a pro-inflammatory dietary pattern, 295 
reflected by a higher DII score, is associated with poorer renal function, a more rapid renal function decline over 296 
10 years, and a higher risk of renal disease-related hospitalization and/or death. Further research is warranted to 297 
confirm the association between the inflammatory potential of the diet and kidney function as well as to verify 298 
these findings in other population groups.  299 
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Table 1. Baseline characteristics of study population 
 Total population 
n=1422 












DII, mean [range] 0.19 [-6.14, 6.39] -2.83 [-6.14, -1.72] -1.02 [-1.73, -0.38] 0.18 [-0.39, 0.76] 1.40 [0.77, 2.13] 3.18 [2.14, 6.39]  
Demographics        
Age (years) 75.2 ± 2.7 75.3 ± 2.7 75.0 ± 2.7 75.3 ± 2.7 75.2 ± 2.7 75.1 ± 2.8 0.69 
Body mass index (kg/m2) 27.2 ± 4.8 27.2 ± 4.8 27.0 ± 4.3 27.3 ± 4.6 27.5 ± 4.8 26.9 ± 5.1 0.77 
Energy intake (MJ/d)  7.1 ± 2.1 9.2 ± 2.0 7.7 ± 1.7 7.0 ± 1.4 6.1 ± 1.4 5.4 ± 1.4 <0.001 
Smoked ever, n (%) 530 (37.2) 107 (37.8) 103 (36.3) 96 (33.9) 106 (36.9) 118 (41.4) 0.53 
Physical activity (kJ/day), median 
[IQR] 
470 [114, 857] 554 [213, 901] 488 [219, 906] 469 [0, 800] 464 [100, 850] 354 [0, 795] 0.004 
Alcohol intake (g/d), median [IQR] 0.8 [0.3, 9.8] 1.4 [0.1, 12.9] 2.0 [0.4, 9.9] 2.2 [0.3, 9.3] 1.9 [0.3, 9.8] 1.1 [0.2, 8.0] 0.34 
Diabetes, n (%) 84 (5.9) 16 (5.7) 18 (6.3) 13 (4.6) 20 (7.0) 17 (6.0) 0.78 
ASVD, n (%) 163 (11.4) 32 (11.3) 25 (8.8) 37 (13.1) 38 (13.2) 31 (10.9) 0.44 
Cancer, n (%) 86 (6.0) 14 (4.9) 11 (3.9) 25 (8.8) 19 (6.6) 17 (6.0) 0.14 
eGFR (mL/min per 1.73m2) 65.9 ± 12.8 67.0 ± 12.1 67.5 ± 13.2 64.1 ± 12.9 65.8 ± 12.9 65.2 ± 12.9 0.03 
Medications, n (%)        
Treatment (calcium)  744 (52.3) 157 (55.5) 154 (54.2) 152 (53.7) 140 (48.8) 141 (49.1) 0.54 
Antihypertensive 612 (43.0) 126 (44.5) 141(49.6) 131 (46.3) 123 (42.9) 121 (49.5) 0.59 
NSAIDs for joint pain 469 (33.0) 87 (30.7) 95 (33.5) 101 (35.7) 89 (31.0) 97 (34.0) 0.66 
Statins  269 (18.9) 67 (23.7) 52 (18.3) 52 (18.4) 45 (15.7) 53 (18.6) 0.13 
Data expressed as mean ± SD unless otherwise stated. P-values for comparisons between DII® score quintiles were derived by ANOVA, Kruskal-Wallis H test or x2 test where appropriate. 




















Table 2. Association between DII score and eGFR at baseline (1998), 5 years (2003), and 10 years (2008) and annual rate of 
change in eGFR. 
 N  Model 1 Model 2 
 β (95% CI) p value β (95% CI) p value 
eGFR at baseline 1,111 -0.49 (-0.94, -0.05) 0.03 -0.55 (-0.98, -1.22) 0.01 
eGFR at 5 years 1,022 -0.82 (-1.34, -0.30) <0.01 -0.89 (-1.38, -0.39) <0.01 
eGFR at 10 years 738 -0.80 (-1.51, -0.08) 0.03 -0.92 (-1.60, -0.24) 0.01 
Annual change in eGFR* 998 -0.06 (-0.12, 0) 0.07 -0.06 (-0.12, 0) 0.05 
Association between baseline dietary inflammatory index (DII®) score and estimated glomerular filtration rate (eGFR) at 
baseline, 5 years and 10 years of follow-up, and annual rate of change in eGFR. Estimates were obtained using linear regression 
analyses adjusted for age and energy (Model 1) and age, energy intake, treatment code, BMI, smoking status, physical activity, 
alcohol intake, diabetes status, use of antihypertensive medication, prevalent ASVD, statin use, and use of NSAIDs for joint pain 
(Model 2). *Adjusted for years in which eGFR was measured. 
Table 3.  Risk estimates of renal disease-related events during 10 years of follow-up  
 N (events/total) Model 1 Model 2 
HR (95% CI) p value HR (95% CI) p value 
Baseline DII quintiles      
Q1 (<-1.72) 18/283 1.00 (Referent)  1.00 (Referent)  
Q2 (-1.73, -0.38) 23/284 1.35 (0.71, 2.56) 0.36 1.35 (0.70, 2.58) 0.37 
Q3 (-0.39, 0.76) 27/283 1.53 (0.80, 2.93) 0.20 1.51 (0.78, 2.93) 0.22 
Q4 (0.77, 2.13) 22/287 1.18 (0.57, 2.43) 0.65 1.12 (0.54, 2.33) 0.77 
Q5 (≥2.14) 33/285 1.96 (0.95, 4.05) 0.07 2.06 (0.97, 4.37) 0.06 
DII, Dietary inflammatory index. 
Hazard rations (HR) and 95% confidence intervals (CI) were obtained from Cox proportional hazards models adjusted for age and 
energy (Model 1) and age, energy intake, treatment code, BMI, smoking status, physical activity, alcohol intake, diabetes status, 





Fig. 1 Consort flow diagram.; eGFR, estimated glomerular filtration rate; FFQ, food frequency questionnaire 
 
Fig. 2 Graphic presentation of the multivariable adjusted effect of dietary inflammatory index (DII) on estimated 
glomerular filtration rate (eGFR) in 1,111 elderly Western Australian women at baseline (1998). The vertical axis 
is the difference in eGFR at each DII score relative to the eGFR for the mean DII score. The association was 
obtained from a generalized additive model adjusted for age, energy intake, treatment code, BMI, smoking status, 
physical activity, alcohol intake, diabetes status, use of antihypertensive medication, prevalent ASVD, statin use, 
and use of NSAIDs for joint pain.  
 
Fig. 3 Graphic presentation of the multivariable adjusted effect of dietary inflammatory index (DII) on annual rate 
of change of estimated glomerular filtration rate (eGFR; p=0.08) in 998 elderly Western Australian women during 
10 years of follow-up (1998 - 2008). The vertical axis is the difference in the annual rate of change of eGFR at 
each DII score relative to the annual rate of change of eGFR for the mean DII score. The association was obtained 
from a generalized additive model adjusted for age, energy intake, treatment code, BMI, smoking status, physical 
activity, alcohol intake, diabetes status, use of antihypertensive medication, prevalent ASVD, statin use, use of 
NSAIDs for joint pain, and time of eGFR measurements.  
 
Fig. 4 Cubic spline curves describing the association between Dietary Inflammatory Index score and renal disease-
related events (hospitalization or death); p for non-linearity = 0.04. Hazard ratios are based on Cox proportional 
hazards models adjusted for age, energy intake, treatment code, BMI, smoking status, physical activity, alcohol 
intake, diabetes status, use of antihypertensive medication, prevalent ASVD, statin use, use of NSAIDs for joint 
pain, and are comparing the specific Dietary Inflammatory Index score (horizontal axis) to the median score for 



















Figure 2. Graphic presentation of the multivariable adjusted effect of dietary inflammatory 
index (DII) on estimated glomerular filtration rate (eGFR) in 1,111 elderly Western Australian 
women at baseline (1998). The vertical axis is the difference in eGFR at each DII score relative 
to the eGFR for the mean DII score. The association was obtained from a generalized additive 
model adjusted for age, energy intake, treatment code, BMI, smoking status, physical activity, 
alcohol intake, diabetes status, use of antihypertensive medication, prevalent ASVD, statin use, 







Figure 3. Graphic presentation of the multivariable adjusted effect of dietary inflammatory 
index (DII) on annual rate of change of estimated glomerular filtration rate (eGFR; p=0.08) in 
998 elderly Western Australian women during 10 years of follow-up (1998 - 2008). The 
vertical axis is the difference in the annual rate of change of eGFR at each DII score relative to 
the annual rate of change of eGFR for the mean DII score. The association was obtained from 
a generalized additive model adjusted for age, energy intake, treatment code, BMI, smoking 
status, physical activity, alcohol intake, diabetes status, use of antihypertensive medication, 









Figure 4. Cubic spline curves describing the association between Dietary Inflammatory Index 
score and renal disease-related events (hospitalization or death); p for non-linearity = 0.04. 
Hazard ratios are based on Cox proportional hazards models adjusted for age, energy intake, 
treatment code, BMI, smoking status, physical activity, alcohol intake, diabetes status, use of 
antihypertensive medication, prevalent ASVD, statin use, use of NSAIDs for joint pain, and 
are comparing the specific Dietary Inflammatory Index score (horizontal axis) to the median 
score for participants in the quintile 1 (-2.6). 
